Assignee
ABLEXIS LLC
US·20 granted patents·69 citations·filing 2016–2020
Top patents by PatentIndex Score
20 records- 0198US10836832B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Nov 17, 2020·6 cites·27 claims
- 0297US10829564B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Nov 10, 2020·4 cites·29 claims
- 0397US10494445B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Dec 3, 2019·10 cites·12 claims
- 0496US10604587B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Mar 31, 2020·7 cites·19 claims
- 0596US10526420B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Jan 7, 2020·10 cites·18 claims
- 0695US10618977B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Apr 14, 2020·5 cites·28 claims
- 0795US10575504B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Mar 3, 2020·7 cites·13 claims
- 0894US10662255B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted May 26, 2020·5 cites·27 claims
- 0994US10626188B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Apr 21, 2020·5 cites·22 claims
- 1093US10492476B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Dec 3, 2019·5 cites·10 claims
- 1189US11104743B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Aug 31, 2021·1 cites·20 claims
- 1288US11104744B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Aug 31, 2021·1 cites·20 claims
- 1385US10555506B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Feb 11, 2020·2 cites·12 claims
- 1477US11220555B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2020·Granted Jan 11, 2022·0 cites·20 claims
- 1575US10759861B2Anti-CD115 antibodiesABLEXIS LLC·Filed 2016·Granted Sep 1, 2020·1 cites·14 claims
- 1671US11352444B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Jun 7, 2022·0 cites·11 claims
- 1770US11242409B2Genetic engineering of non-human animals for the production of chimeric antibodiesABLEXIS LLC·Filed 2017·Granted Feb 8, 2022·0 cites·22 claims
- 1864US10638736B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted May 5, 2020·0 cites·23 claims
- 1964US10561123B2Non-human mammals for the production of chimeric antibodiesABLEXIS LLC·Filed 2016·Granted Feb 18, 2020·0 cites·20 claims
- 2059US11753478B2Anti-CD115 antibodiesABLEXIS LLC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when ABLEXIS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →